Primary outcome of the study
| Category . | Patients, n . | Incidence of the primary outcome (95% CI), % . |
|---|---|---|
| Patients with MRDTI negative for both DVT and thrombophlebitis who were not treated with any anticoagulant during follow-up* | 119 | 1.7 (0.20-5.9) |
| All patients with MRDTI negative for DVT | 189 | 1.1 (0.13-3.8) |
| Category . | Patients, n . | Incidence of the primary outcome (95% CI), % . |
|---|---|---|
| Patients with MRDTI negative for both DVT and thrombophlebitis who were not treated with any anticoagulant during follow-up* | 119 | 1.7 (0.20-5.9) |
| All patients with MRDTI negative for DVT | 189 | 1.1 (0.13-3.8) |
Patients who developed thrombophlebitis during follow-up were not included in this cohort because they received a course of anticoagulant treatment.